Cancer Dependency Map Consortium Advances to Phase 3 to Fast-Track Next-Generation Therapeutics
The Broad Institute’s Cancer Dependency Map Consortium (DMC) is poised to revolutionize the field of oncology with the launch of its third phase, marking a...















